Massachusetts General Hospital Interstitial Lung Disease Center
The Interstitial Lung Disease Center at Massachusetts General Hospital specializes in diagnosing and treating the full spectrum of interstitial lung diseases, including pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, and less common disorders such as lymphangioleiomyomatosis (LAM), Langerhans cell histiocytosis (LCH), and cryptogenic organizing pneumonia (COP). A comprehensive patient care at the center also has the ability to address complications of these disorders (e.g. pulmonary hypertension) that can greatly compromise quality of life. The center includes pulmonologists, chest radiologists and pathologists, thoracic surgeons and research scientists.
The center is led by co-directors Leo Ginns, M.D. and Andrew Tager, M.D. A member of the Pulmonary and Critical Care Unit since 1977, Dr. Ginns has conducted basic research in immunology of lung disease and clinical research in lung transplantation and advanced lung disease. He served as medical director of the Mass General Transplant Program from 1990 until 2010, when he became director of our Center for Advanced Lung Disease.
Dr. Tager joined the Division of Pulmonary and Critical Care Medicine in 1999 after completing a research fellowship investigating several lung diseases, including pulmonary fibrosis, asthma and cystic fibrosis. He since has focused on pulmonary fibrosis and in recent years has received international recognition for his work in identifying new pathways by which this disease may develop. His research today continues to be centered on understanding the causes of fibrotic lung diseases, such as idiopathic pulmonary fibrosis.